REmote MOnitoring of paTiEnts witH pacEmaker or implAntable cardioverteR defibrillaTor
REMOTE-HEART
1 other identifier
observational
800
1 country
1
Brief Summary
However, the current guidelines recommend the use of remote monitoring (RM) in patients with cardiac implantable electronic devices (CIED) to reduce inappropriate shocks or early detection of atrial fibrillation, data is incomprehensive on the effectiveness of decreasing heart failure events or mortality in patients with heart failure and reduced ejection fraction (HFrEF). The only randomized trial, which proved the efficacy of RM on mortality was the IN-TIME trial, which used a strict protocol for detection and intervention of the heart failure events. The primary aim of this study is to optimize the use of remote monitoring system in HFrEF patients already implanted an implantable cardiac defibrillator (ICD) or a cardiac resynchronization therapy (CRT). By creating a high-quality system with structured safety-net, which is able to use the data of remote monitoring messages and alerts of our patients, we can improve their outcome. The primary endpoint is the non-fatal heart failure event or all-cause mortality. Secondary outcomes include all-cause mortality, cardiovascular mortality, heart failure hospitalization, cardiovascular hospitalization, unscheduled visits, af burden, stroke, inappropriate shocks, quality of life, NYHA functional class. By using artificial intelligence-based methods, the optimal cut-off values of the previously, empirically used alert parameters will be validated or challenged. Additionally, cost-effectiveness to reduce the hospitalizations will be calculated. Due to this remote monitoring structured safety-net, these patients with severe heart failure can be treated more efficiently, safely and cost-effectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 28, 2023
CompletedFirst Posted
Study publicly available on registry
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedDecember 15, 2023
January 1, 2023
2.4 years
November 28, 2023
December 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The composite of all-cause mortality, heart failure events
12 months
Secondary Outcomes (3)
cardiovascular mortality
12 months
cardiovascular hospitalization
12 months
unscheduled visits
12 months
Other Outcomes (2)
Change in Kansas City Cardiomyopathy Questionnaire score
12 months
change of symptoms (assessed by NYHA classification)
12 months
Interventions
Remote monitoring for patients with an ICD/CRT device
Eligibility Criteria
chronic heart failure with reduced ejection fraction (HFrEF) with an implanted CIED (CRT/ICD) eligible for home monitoring
You may qualify if:
- CRT-P/CRT-D patients with a feasible device for home monitoring
- ICD (VVI/VDD/DDD) patients with a feasible device for home monitoring
- SR/AFib
- Transmission performance \>80% in the first 2 weeks with new device
- Informed consent
You may not qualify if:
- Life expectancy\<1 year
- Unable to transmit data
- Patient is unable to visit the physician/clinic in 12 hours when it is indicated by the alerts
- Expected non-compliance
- Pregnancy
- Known drug, alcohol abuse
- Participation in other study or HM system concept
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Semmelweis University - Heart and Vascular Center
Budapest, 1122, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2023
First Posted
December 15, 2023
Study Start
January 30, 2023
Primary Completion
June 30, 2025
Study Completion
August 30, 2025
Last Updated
December 15, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share